Login / Signup

Endovascular treatment with interwoven nitinol stent for common femoral artery lesions: 2-year outcomes of a single center experience.

Veera SuwanruangsriSurakiat BokerdVirapat ChanchitsoponSirakarn Jowcharoen
Published in: Vascular (2024)
Endovascular treatment with interwoven nitinol (Supera™) stent for CFA lesions was associated with acceptable outcomes at 2 years.
Keyphrases
  • endovascular treatment
  • metabolic syndrome
  • skeletal muscle
  • glycemic control
  • weight loss